With the support of the National Institute on Drug Abuse, scientists at Wake Forest School of Medicine have been working to find a safe, non-addictive pain killer to help fight the current opioid crisis in this country.
And they may have done just that, though in an animal model.
Known as AT-121, the new chemical compound has dual therapeutic action that suppressed the addictive effects of opioids and produced morphine-like analgesic effects in non-human primates.
“In our study, we found AT-121 to be safe and non-addictive, as well as an effective pain medication,” said Mei-Chuan Ko, Ph.D., professor of physiology and pharmacology at the School of Medicine, part of Wake Forest Baptist Medical Center.
“In addition, this compound also was effective at blocking abuse potential of prescription opioids, much like buprenorphine does for heroin, so we hope it could be used to treat pain and opioid abuse.”
The findings are published in the Aug. 29 issue of the journal Science Translational Medicine.
The main objective of this study was to design and test a chemical compound that would work on both the mu opioid receptor, the main component in the most effective prescription pain killers, and the nociceptin receptor, which opposes or blocks the abuse and dependence-related side effects of mu-targeted opioids. Current opioid pain drugs, such as fentanyl and oxycodone, work only on the mu opioid receptor, which also produces unwanted side effects – respiratory depression, abuse potential, increased sensitivity to pain and physical dependence.
“We developed AT-121 that combines both activities in an appropriate balance in one single molecule, which we think is a better pharmaceutical strategy than to have two drugs to be used in combination,” Ko said.
In the study, the researchers observed that AT-121 showed the same level of pain relief as an opioid, but at a 100-times lower dose than morphine. At that dose, it also blunted the addictive effects of oxycodone, a commonly abused prescription drug.
The bifunctional profile of AT-121 not only gave effective pain relief without abuse potential, it also lacked other opioid side-effects that patients typically struggle with, such as itch, respiratory depression, tolerance and dependence.
“Our data shows that targeting the nociceptin opioid receptor not only dialed down the addictive and other side-effects, it provided effective pain relief,” Ko said. “The fact that this data was in nonhuman primates, a closely related species to humans, was also significant because it showed that compounds, such as AT-121, have the translational potential to be a viable opioid alternative or replacement for prescription opioids.”
Next steps include conducting additional preclinical studies to collect more safety data, and then if all goes well, applying to the Food and Drug Administration for approval to begin clinical trials in people, Ko said.
The Latest on: Non-addictive pain killer
via Google News
The Latest on: Non-addictive pain killer
- Global Antimicrobial Coating Market Report 2020 - Leading Manufacturers are AkzoNobel, Sherwin-Williams, PPG, Axalta and BASFon March 21, 2020 at 5:38 pm
Dublin, March 20, 2020 -- The "Antimicrobial Coating Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's.
- Global Wind Turbine Materials Market, Forecast to 2026on March 20, 2020 at 3:31 am
The wind turbine materials market is bifurcated into structural and non-structural materials. The structural materials market is further divided into metals, Fiber-Reinforced Composites (FRC) and core ...
- Global Forecast for Anti-Icing Coating to 2026 - High Tech & Emerging Markets Report - ResearchAndMarkets.comon March 19, 2020 at 6:48 pm
High Tech & Emerging Markets Report" report has been added to ResearchAndMarkets.com's offering. This report contains timely and accurate market statistics and forecasts on the market for over 140 ...
- Roof Coating Market Latest Advancement And New Upcoming Trends To 2029on March 19, 2020 at 1:15 am
A recent market research analysis titled, Roof Coating Market offers insightful information to the clients escalating their basic leadership size explores distinct significant facets associated with ...
- North America Floor Coating Market to 2027on March 18, 2020 at 8:08 pm
Reportlinker.com announces the release of the report "North America Floor Coating Market to 2027 - Regional Analysis and Forecasts by Type ; Formulation ; Coating Component ; Flooring Material , ...
- Nanobiohybrids: Materials approaches for bioaugmentationon March 18, 2020 at 12:08 pm
Inspired by the complexity of naturally evolved shells, such as diatoms, silica and silicate materials have been exploited in bioaugmentation as protective coatings for biological systems (22). Silica ...
- Smart Coating Market Regional Growth, Trends, Revenue, Analysis And Forecast by 2025on March 18, 2020 at 5:08 am
According to BlueWeave ConsultingShare , the Global Smart Coating Market is expected to grow at a significant rate during the forecast period. The Global Smart Coating Market size is valued at ...
- Custom Chemicals and Coating shifts to make hand sanitizer during shortage amid coronavirus outbreakon March 17, 2020 at 3:20 pm
PEARLAND, Texas (KTRK) -- A local chemical company, that usually makes industrial coatings, is shifting its focus to make hand sanitizer during ... He admits there are challenges, like getting the raw ...
- Roper Cites Research Work On Coating To Cloak IR Signatureson March 17, 2020 at 12:39 pm
A coating that could cloak objects from infrared sensors by controlling their thermal radiation has been demonstrated by researchers at U.S. universities, with funding support from the U.S. Air Force ...
- Analysis on World Markets for Paints & Coatings Fillers, 2019-2027on March 16, 2020 at 5:18 am
The "Paints & Coatings Fillers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering. This publication ...
via Bing News